NPIPA5
geneOn this page
Summary
NPIPA5 (nuclear pore complex interacting protein family member A5, HGNC:41980) is a protein-coding gene on chromosome 16p13.11, encoding Nuclear pore complex-interacting protein family member A5 (E9PKD4).
At a glance
- Clinical variants (ClinVar): 9 total — 2 pathogenic
- MANE Select transcript:
NM_001277325
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:41980 |
| Approved symbol | NPIPA5 |
| Name | nuclear pore complex interacting protein family member A5 |
| Location | 16p13.11 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000183793 |
| Ensembl biotype | protein_coding |
| Entrez | 100288332 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 protein_coding
ENST00000360151, ENST00000534094, ENST00000543801
RefSeq mRNA: 2 — MANE Select: NM_001277325
NM_001277325, NM_001351200
CCDS: CCDS59264, CCDS86506
Canonical transcript exons
ENST00000360151 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002140663 | 15365429 | 15365464 |
| ENSE00002145121 | 15365574 | 15365634 |
| ENSE00002152756 | 15370020 | 15370119 |
| ENSE00002154441 | 15373715 | 15373843 |
| ENSE00002157002 | 15366653 | 15366760 |
| ENSE00002176057 | 15363628 | 15364069 |
| ENSE00002182767 | 15378232 | 15378294 |
| ENSE00003502055 | 15369712 | 15369856 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 97.65.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primary visual cortex | UBERON:0002436 | 97.65 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 96.77 | gold quality |
| cerebellar cortex | UBERON:0002129 | 96.59 | gold quality |
| cerebellum | UBERON:0002037 | 96.54 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 96.50 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 94.45 | gold quality |
| mucosa of stomach | UBERON:0001199 | 93.87 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 92.44 | gold quality |
| right frontal lobe | UBERON:0002810 | 91.91 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 91.69 | gold quality |
| left testis | UBERON:0004533 | 91.52 | gold quality |
| Ammon’s horn | UBERON:0001954 | 91.43 | gold quality |
| hypothalamus | UBERON:0001898 | 91.39 | gold quality |
| right testis | UBERON:0004534 | 91.28 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 91.28 | gold quality |
| amygdala | UBERON:0001876 | 91.26 | gold quality |
| pituitary gland | UBERON:0000007 | 90.95 | gold quality |
| apex of heart | UBERON:0002098 | 90.82 | gold quality |
| temporal lobe | UBERON:0001871 | 90.77 | gold quality |
| testis | UBERON:0000473 | 90.30 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 89.62 | gold quality |
| left ovary | UBERON:0002119 | 89.50 | gold quality |
| substantia nigra | UBERON:0002038 | 89.27 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 89.23 | gold quality |
| putamen | UBERON:0001874 | 89.15 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.05 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 89.03 | gold quality |
| adenohypophysis | UBERON:0002196 | 88.82 | gold quality |
| caudate nucleus | UBERON:0001873 | 88.70 | gold quality |
| nucleus accumbens | UBERON:0001882 | 88.58 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.71 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Paralogs (19): NPIPB12 (ENSG00000169203), NPIPB3 (ENSG00000169246), NPIPA1 (ENSG00000183426), NPIPA6 (ENSG00000183889), NPIPB4 (ENSG00000185864), NPIPB15 (ENSG00000196436), NPIPB9 (ENSG00000196993), NPIPB13 (ENSG00000198064), NPIPB6 (ENSG00000198156), NPIPA8 (ENSG00000214940), NPIPA7 (ENSG00000214967), NPIPA3 (ENSG00000224712), NPIPA9 (ENSG00000233024), NPIPB7 (ENSG00000233232), NPIPB2 (ENSG00000234719), NPIPB5 (ENSG00000243716), NPIPB11 (ENSG00000254206), NPIPA2 (ENSG00000254852), NPIPB8 (ENSG00000255524)
Protein
Protein identifiers
Nuclear pore complex-interacting protein family member A5 — E9PKD4 (reviewed: E9PKD4)
All UniProt accessions (2): E9PJ88, E9PKD4
UniProt curated annotations — full annotation on UniProt →
Similarity. Belongs to the NPIP family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| E9PKD4-1 | 1 | yes |
| E9PKD4-2 | 2 |
RefSeq proteins (2): NP_001264254, NP_001338129 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR009443 | NPIP | Family |
| IPR054697 | NPIP_N | Domain |
Pfam: PF06409
UniProt features (4 total): splice variant 2, chain 1, region of interest 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-E9PKD4-F1 | 52.14 | 0.00 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 3 (showing top):
ZHONG_PFC_C3_ASTROCYTE, HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL, chr16p13
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
849 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPIPA5 | GOLGA6B | A6NDN3 | 507 |
| NPIPA5 | PDXDC1 | Q6P996 | 479 |
| NPIPA5 | LRRC37A3 | O60309 | 447 |
| NPIPA5 | NUP62 | P37198 | 439 |
| NPIPA5 | MPV17L | Q2QL34 | 419 |
| NPIPA5 | H3BMD7 | H3BMD7 | 400 |
| NPIPA5 | CEP20 | Q96NB1 | 395 |
| NPIPA5 | LRRC37A | A6NMS7 | 391 |
| NPIPA5 | AGAP6 | Q5VW22 | 377 |
| NPIPA5 | NBPF4 | Q96M43 | 360 |
| NPIPA5 | NASP | P49321 | 355 |
| NPIPA5 | LENG1 | Q96BZ8 | 352 |
| NPIPA5 | MARF1 | Q9Y4F3 | 339 |
| NPIPA5 | TRIM51 | Q9BSJ1 | 321 |
| NPIPA5 | GARIN4 | Q8IYT1 | 317 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0B4J1W7, A0A7H0DN35, A4QN01, A6NHN6, A6NJ64, A8MQ11, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F5HGC2, F8W1W9, F8WFD2, O75200, O83374, P05913, P06486, P07396, P0C7Q2, P0CK47, P0CK48, P0DM63, P0DXC3, P15489, P16765, P16802, P20969, P36443, P38900, P47003, P68341, P68454, P68455, P87191, P92537, P92561, Q03418, Q32M92, Q4ZGE2
Diamond homologs: A0A0B4J1W7, A6NHN6, A6NJ64, A6NJU9, A8MRT5, C9JG80, E5RHQ5, E9PIF3, E9PJ23, E9PJI5, E9PKD4, E9PQR5, F8W0I5, F8W1W9, F8WFD2, O75200, P0DM63, P0DXC3, Q92617, Q9UND3, O70490, Q08AH1, Q08AH3, Q3UNX5, Q53FZ2, Q5REV5, Q68CK6, Q6AYT9, Q6NUN0, Q6SKG1, Q8BGA8, Q8K0L3, Q91VA0, Q9BEA2
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
9 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 2 |
| Likely pathogenic | 0 |
| Uncertain significance | 3 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (2)
| Variant ID | HGVS | Classification |
|---|---|---|
| 625566 | GRCh37/hg19 16p13.11(chr16:14975292-16301530) | Pathogenic |
| 625597 | GRCh37/hg19 16p13.11(chr16:15129970-16284116) | Pathogenic |
SpliceAI
986 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:15365572:A:AC | donor_gain | 1.0000 |
| 16:15365573:C:CC | donor_gain | 1.0000 |
| 16:15366651:A:AC | donor_gain | 1.0000 |
| 16:15366652:C:CC | donor_gain | 1.0000 |
| 16:15366757:CAGA:C | acceptor_gain | 1.0000 |
| 16:15366761:C:CC | acceptor_gain | 1.0000 |
| 16:15369710:A:AC | donor_gain | 1.0000 |
| 16:15369711:C:CA | donor_gain | 1.0000 |
| 16:15369711:CTGTT:C | donor_gain | 1.0000 |
| 16:15369728:T:TA | donor_gain | 1.0000 |
| 16:15370018:ACCTT:A | donor_gain | 1.0000 |
| 16:15370019:CCTTC:C | donor_gain | 1.0000 |
| 16:15370022:T:A | donor_gain | 1.0000 |
| 16:15370044:T:TA | donor_gain | 1.0000 |
| 16:15370117:CAC:C | acceptor_gain | 1.0000 |
| 16:15370118:ACC:A | acceptor_loss | 1.0000 |
| 16:15370119:CCTA:C | acceptor_loss | 1.0000 |
| 16:15370120:CTA:C | acceptor_loss | 1.0000 |
| 16:15370121:T:C | acceptor_loss | 1.0000 |
| 16:15373706:TATAC:T | donor_loss | 1.0000 |
| 16:15373708:TACT:T | donor_loss | 1.0000 |
| 16:15373709:AC:A | donor_loss | 1.0000 |
| 16:15373710:C:CG | donor_loss | 1.0000 |
| 16:15373711:T:TA | donor_loss | 1.0000 |
| 16:15373713:A:AC | donor_gain | 1.0000 |
| 16:15373713:A:AT | donor_loss | 1.0000 |
| 16:15373714:C:CG | donor_gain | 1.0000 |
| 16:15373714:CA:C | donor_gain | 1.0000 |
| 16:15373714:CACA:C | donor_gain | 1.0000 |
| 16:15373714:CACAA:C | donor_gain | 1.0000 |
AlphaMissense
2278 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:15365625:A:C | F185L | 0.965 |
| 16:15365625:A:T | F185L | 0.965 |
| 16:15365627:A:G | F185L | 0.965 |
| 16:15373799:A:C | F36L | 0.928 |
| 16:15373799:A:T | F36L | 0.928 |
| 16:15373801:A:G | F36L | 0.928 |
| 16:15369828:A:C | F107L | 0.914 |
| 16:15369828:A:T | F107L | 0.914 |
| 16:15369830:A:G | F107L | 0.914 |
| 16:15373763:A:C | F48L | 0.909 |
| 16:15373763:A:T | F48L | 0.909 |
| 16:15373765:A:G | F48L | 0.909 |
| 16:15370111:G:C | F67L | 0.897 |
| 16:15370111:G:T | F67L | 0.897 |
| 16:15370113:A:G | F67L | 0.897 |
| 16:15365463:A:G | I203T | 0.875 |
| 16:15366665:A:G | I178T | 0.874 |
| 16:15365574:T:A | K202N | 0.861 |
| 16:15365574:T:G | K202N | 0.861 |
| 16:15364061:C:A | M217I | 0.855 |
| 16:15364061:C:G | M217I | 0.855 |
| 16:15364061:C:T | M217I | 0.855 |
| 16:15365626:A:G | F185S | 0.835 |
| 16:15370105:C:A | K69N | 0.832 |
| 16:15370105:C:G | K69N | 0.832 |
| 16:15373786:A:G | W41R | 0.829 |
| 16:15373786:A:T | W41R | 0.829 |
| 16:15365463:A:C | I203S | 0.826 |
| 16:15366699:C:G | A167P | 0.823 |
| 16:15369729:C:A | R140S | 0.822 |
dbSNP variants (sampled 300 via entrez): RS1000286020 (16:15383376 C>T), RS1000550905 (16:15369972 C>A), RS1000876498 (16:15382139 C>T), RS1000929824 (16:15376117 A>G), RS1001052689 (16:15368782 C>A,G), RS1001137791 (16:15368513 T>A), RS1001350440 (16:15376392 G>A), RS1001818587 (16:15380671 T>C), RS1001870822 (16:15381085 C>A,T), RS1001956183 (16:15374914 G>A), RS1002089246 (16:15367272 G>C), RS1002387650 (16:15374440 C>T), RS1002877306 (16:15379958 AAT>A,AATAT), RS1002982724 (16:15372006 C>T), RS1003061256 (16:15364254 G>C,T)
Disease associations
OMIM: gene `` | disease phenotypes: MIM:157900
GenCC curated gene-disease
Mondo (1): Mobius syndrome (MONDO:0008006)
Orphanet (1): Moebius syndrome (Orphanet:570)
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
MeSH disease descriptors (1)
| Descriptor | Name | Tree numbers |
|---|---|---|
| D020331 | Mobius Syndrome | C07.465.299.825; C10.292.319.825; C10.292.562.700.375.750; C11.590.436.400.750; C16.131.077.578; C16.614.595 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
8 total (human), top 8 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| mivebresib | increases expression | 1 |
| ethyl-p-hydroxybenzoate | decreases expression | 1 |
| sodium arsenite | decreases expression | 1 |
| (+)-JQ1 compound | increases expression | 1 |
| Cadmium | decreases expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
1 trials via MONDO — disease-level, not drug-specific.
| Trial | Phase | Status | Title |
|---|---|---|---|
| NCT03059420 | Not specified | RECRUITING | Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies |
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): Mobius syndrome